Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › salmeterol

salmeterol

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of salmeterol

23 trials tracked of salmeterol: 14 in phase 3 or 4 and 1 with published results. The most-cited published study has 18 citations.

23Trials tracked
14Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 8 Phase 3 6 Phase 2 4 Phase 1 1 Other / NA 4
  1. Phase 3 A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma Completed · 18 cited
  2. Phase 4 Cardiovascular Function in COPD Patients Completed
  3. Phase 4 The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus Completed
  4. Phase 4 The Effects of Montelukast on Smokers With Asthma Completed
  5. Phase 4 Effects of Salmeterol on Autonomic Nervous System Completed
  6. Phase 4 Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients. Completed
Show 17 more trials
  1. Phase 4 Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease Completed
  2. Phase 4 Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.) Completed
  3. Phase 4 Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD Completed
  4. Phase 3 Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) Completed
  5. Phase 3 Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD) Completed
  6. Phase 3 Efficacy and Safety of Different Doses of Indacaterol Completed
  7. Phase 3 Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT) Completed
  8. Phase 3 Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients Completed
  9. Phase 2 Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) Completed
  10. Phase 2 Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol Completed
  11. Phase 2 Dose Ranging Study for Indacaterol in Japanese Asthma Patients Completed
  12. Phase 2 Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler® Completed
  13. Phase 1 Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate Completed
  14. N/A Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway Completed
  15. N/A Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease Completed
  16. N/A How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment Completed
  17. N/A The Effect of Salmeterol on Eosinophil (EOS) Function Completed

Showing the 23 most-cited and recently-updated of 23 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.